A new, patent-pending encapsulation and delivery system has been introduced by Amerchol, a business unit of The Dow Chemical Company and its consolidated affiliates.
The introduction of the SatinFX delivery system is another example of Amerchol’s strategy to bring new technologies to the personal care industry in support of market needs meant to fulfil the increasingly sophisticated demands of the consumer.
The SatinFX delivery system helps to address formulators’ need to improve the stability and delivery of active ingredients, in response to the consumer demand for more effective, multifunctional skin care products.
“Improving the stability of sensitive actives such as vitamin C is a critical need of many skin care formulators,” commented Denise Elias-Costrini, global marketing manager of Amerchol. “Our SatinFX delivery system provides enhanced stability over time, which helps prevent oxidation of the actives and discoloration of the finished product.”
In addition to enhanced stability, the SatinFX delivery system also enables the encapsulation of “incompatible” ingredients to provide multiple performance benefits. For example, it can be used to encapsulate dihydroxyacetone (DHA) and amino acids to create sunless tanning products that also provide anti-ageing benefits.
The SatinFX delivery system can also be used to improve the aesthetic properties of many formulations such as facial creams, eye gels and serums, and body lotions.
Denise Elias-Costrini said: “Some actives provide significant benefits to the skin, such as alpha hydroxy acids, but they can also be very irritating. By encapsulating these actives, the potential for skin irritation is reduced, which helps to provide a better experience for the consumer.”
